Published in Cancer on February 01, 1994
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer (1998) 1.53
Matrix metalloproteinases and their inhibitors in gastric cancer. Gut (1998) 1.30
Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem (2004) 1.00
Relationship between collagen IV expression and biological behavior of gastric cancer. World J Gastroenterol (2000) 0.86
MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer. Cancer Sci (2014) 0.85
Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study. J Clin Pathol (1998) 0.82
Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. Cancer Microenviron (2010) 0.80
MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression. Diagn Pathol (2015) 0.77
Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis. Lab Invest (2014) 0.76
Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma. Oncol Lett (2016) 0.76
Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome. Mol Clin Oncol (2016) 0.75
Tenascin and oncofetal fibronectin--oncofetal markers or indicators of extracellular matrix remodelling? Br J Cancer (1996) 0.75
α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression. Int J Oncol (2017) 0.75
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology (2001) 2.89
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer (1997) 2.64
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol (2000) 2.61
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol (2008) 2.37
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol (2003) 2.13
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
Metaplastic breast carcinomas are basal-like tumours. Histopathology (2006) 1.80
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol (1997) 1.79
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res (2001) 1.75
Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol (1994) 1.70
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy (1986) 1.66
Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract (1995) 1.65
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci U S A (1991) 1.65
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat (1999) 1.63
E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol (1998) 1.61
Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res (1994) 1.58
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol (2001) 1.54
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. J Natl Cancer Inst (1990) 1.53
Molecular genetic changes in human male germ cell tumors. Lab Invest (1995) 1.53
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer. J Clin Oncol (2000) 1.51
Small cell carcinoma of the ovary. A report of six cases. Int J Gynecol Pathol (1988) 1.51
Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology (1996) 1.51
E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest (1999) 1.47
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab (2005) 1.46
Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer Genet Cytogenet (1992) 1.45
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. J Pathol (1999) 1.44
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol (1998) 1.44
[Prolonged neck pain following automobile accidents. Gender and age related risk calculated on basis of data from an emergency department]. Ugeskr Laeger (2000) 1.41
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis (1999) 1.40
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer (2005) 1.39
[Telepathology at the Norwegian Radium Hospital]. Tidsskr Nor Laegeforen (2000) 1.39
[Changes in spongiosa fine structure under the influence of polymerizing bone cement (scanning electron microscopic studies)]. Z Orthop Ihre Grenzgeb (1970) 1.35
MUC1 gene polymorphism and gastric cancer--an epidemiological study. Glycoconj J (1997) 1.32
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res (1997) 1.30
Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer (1993) 1.30
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res (1988) 1.29
Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol (1996) 1.29
Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer (1992) 1.26
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem (2000) 1.25
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer (2001) 1.24
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol (1998) 1.23
New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract (1995) 1.22
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer (1992) 1.22
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer (1988) 1.21
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer (2001) 1.21
Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B (1996) 1.19
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res (2000) 1.19
Comparison of two intervention programmes in young female players in European handball--with and without ankle disc. Scand J Med Sci Sports (2003) 1.18
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics (2011) 1.18
The origin and significance of thyroid psammoma bodies. Lab Invest (1980) 1.17
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am J Pathol (1998) 1.17
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol (1993) 1.16
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene (2010) 1.16
Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch (2000) 1.16
Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology (1998) 1.15
[Electron microscopic scanning in normal and arthrotic articular cartilage]. Z Orthop Ihre Grenzgeb (1970) 1.13
SYBR green I DNA staining increases the detection sensitivity of viruses by polymerase chain reaction. J Virol Methods (1995) 1.12
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour. Acta Oncol (1995) 1.11
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer (1998) 1.11
E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology (2003) 1.10
Yet another machine fault. Anesthesiology (1983) 1.09
Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol (2000) 1.09
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch (2000) 1.09
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene (2001) 1.09
Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int J Cancer (1986) 1.09
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. Br J Cancer (2004) 1.08
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol (1993) 1.08
p53 abnormalities in different subtypes of human sarcomas. Cancer Res (1993) 1.07
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br J Cancer (2002) 1.07
Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl (1992) 1.07
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J Clin Oncol (1999) 1.07
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Clin Cancer Res (2001) 1.06
Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol (1997) 1.06
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer (1997) 1.05
Disseminated tumour cells as a prognostic biomarker in colorectal cancer. Br J Cancer (2011) 1.04
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer (1994) 1.02
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer (1996) 1.02
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol (2005) 1.02
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer (1998) 1.01
E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer (1997) 1.01
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer. Anticancer Res (2000) 1.01